HOME > PARTNERS > THOMSON REUTERS

PARTNERS



Thomson Reuters, Life Sciences

Knowledge around disease pathways is rapidly increasing. Contextualizing systems biology data for life science research and drug discovery expands the possibilities for successful R&D. Thomson Reuters manually curated systems biology intelligence and unique understanding of pathways, Omics, and pharmacology make us the trusted partner of research institutions and R&D departments all over the world.

We combine expert analysis in use of our content and technology assets, proprietary analytical and visualization tools, and deep expertise in the pharmaceutical and life sciences business to develop tailored solutions that meet the industry’s unique business needs for faster, more informed decisions with higher confidence. From discovery to launch and beyond, at every stage of the pipeline our experts and intelligence put us in the unique position to help research organizations accomplish their goals.